Israel vs New Zealand: Coverage of the human papillomavirus vaccine
Israel
51
in 2025
New Zealand
52
in 2025
Israel rank
62nd
New Zealand rank
61st
Coverage of the human papillomavirus vaccine over time
- Israel
- New Zealand
How they compare
New Zealand currently reports 52 against 51 in Israel, a difference of 1.
The two have swapped places 2 times across 10 shared years of data; in 2016 it was New Zealand ahead.
Israel ranks 62nd and New Zealand ranks 61st of 85 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Israel | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 52.5 | 59.25 | 6.75 | New Zealand |
| 2020s | 54 | 62.17 | 8.17 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Israel or New Zealand?
- New Zealand, at 52 against 51 in Israel as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Israel and New Zealand?
- 1, with New Zealand ahead.
- How many years of comparable data are there for Israel and New Zealand?
- 10 years are reported by both, from 2016 to 2025.
- How do Israel and New Zealand rank globally for coverage of the human papillomavirus vaccine?
- Israel ranks 62nd and New Zealand ranks 61st of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.